Compounded medications can be legally prepared during shortage periods (which semaglutide has experienced intermittently) despite patent protection
Semaglutide, a medication currently approved for the treatment of type 2 diabetes and obesity, has shown potential benefits for asthma patients
WADA 2026 Prohibited List Status (S2.2.3 Growth Hormone Fragments) AOD-9604 is named explicitly on the World Anti-Doping Agency 2026 Prohibited List under section S2.2.3 (Growth hormone, its analogs and fragments), prohibited at all times, both in-competition and out-of-competition
Some studies suggest that weight loss and improved metabolic health may support better hormone balance and sperm production, but more data is needed
Hospitalization Study A study published in JAMA Psychiatry in 2024 found that treatment with semaglutide (and liraglutide) reduces the risk of hospitalization for individuals with alcohol use disorder who also have obesity or type 2 diabetes
Still mulling over the best Wegovy dosage for you